Lv4
715 积分 2021-08-29 加入
Design and optimization strategies of PROTACs and its Application, Comparisons to other targeted protein degradation for multiple oncology therapies
10天前
已完结
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
10天前
已完结
Bavdegalutamide (ARV-110): a potent PROTAC androgen receptor degrader for the treatment of metastatic-castration resistant prostate cancer
10天前
已完结
Development of a new permeability assay using low‐efflux MDCKII cells
18天前
已完结
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
21天前
已完结
A DRUG HUNTER’S APPROACH TO MOLECULAR GLUES
25天前
已完结
Initial Treatment of Burns of the Hand
25天前
已完结
TRAF6 promotes IL-4-induced M2 macrophage activation by stabilizing STAT6
26天前
已完结
Identification of an allosteric site on the E3 ligase adapter cereblon
1个月前
已完结
Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies
1个月前
已完结
皖公网安备34019202002308
